Cambridge Cognition

About:

Cognitive assessment software for clinical trials, academic research and healthcare

Website: http://www.cambridgecognition.com/

Top Investors: Alzheimer's Drug Discovery Foundation

Description:

Cambridge Cognition is a neuroscience digital health company developing products and technologies to enhance research of the brain and measure cognitive health and wellbeing in patients worldwide.

Total Funding Amount:

$1.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Bottisham, Cambridgeshire, United Kingdom

Founded Date:

2002-01-01

Contact Email:

info(AT)camcog.com

Founders:

John Hammond

Number of Employees:

51-100

Last Funding Date:

2024-05-29

IPO Status:

Public

Industries: